Fig. 1.
Standard design of phase I toxicity study (to determine maximum tolerated dose [MTD] of drug) and phase II efficacy study in patients with recurrent malignant glioma. Abbreviation: PK, pharmacokinetic.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.